| Literature DB >> 34147798 |
Xiangping Chen1, Lei Lei1, Sitian Liu1, Jian Han1, Ruiwen Li2, Jun Men1, Lin Li3, Lin Wei3, Yaqi Sheng4, Lihua Yang5, Bingsheng Zhou1, Lizhong Zhu4.
Abstract
The consumption of pharmaceuticals and personal care products (PPCPs) for controlling and preventing the COVID-19 would have sharply increased during the pandemic. To evaluate their post-pandemic environmental impacts, five categories of drugs were detected in lakes and WWTP-river-estuary system near hospitals of Jinyintan, Huoshenshan and Leishenshan in the three regions (J, H and L) (Regions J, H and L) in Wuhan, China. The total amount of PPCPs (ranging from 2.61 to 1122 ng/L in water and 0.11 to 164 ng/g dry weight in sediments) were comparable to historical reports in Yangtze River basin, whereas the detection frequency and concentrations of ribavirin and azithromycin were higher than those of historical studies. The distribution of concerned drugs varied with space, season, media and water types: sampling sites located at WWTPs-river-estuary system around two hospitals (Regions L and J) usually had relatively high waterborne contamination levels, most of which declined in autumn; lakes had relatively low waterborne contamination levels in summer but increased in autumn. The potential risks of detected PPCPs were further evaluated using the multiple-level ecological risk assessment (MLERA): sulfamethoxazole and azithromycin were found to pose potential risks to aquatic organisms according to a semi-probabilistic approach and classified as priority pollutants based on an optimized risk assessment. In general, the COVID-19 pandemic did not cause serious pollution in lakes and WWTPs-river-estuary system in Wuhan City. However, the increased occurrence of certain drugs and their potential ecological risks need further attention. A strict source control policy and an advanced monitoring and risk warning system for emergency response and long-term risk control of PPCPs is urgent.Entities:
Keywords: Antibiotics; Antiviral drugs; COVID-19 pandemic; PPCPs; Risk assessment; Wastewater treatment plants
Mesh:
Substances:
Year: 2021 PMID: 34147798 PMCID: PMC8197610 DOI: 10.1016/j.scitotenv.2021.148352
Source DB: PubMed Journal: Sci Total Environ ISSN: 0048-9697 Impact factor: 7.963
Fig. 1Map showing the sampling sites in the lakes and WWTP-river-estuary system in Wuhan City.
Occurrence of ribavirin, antibiotics and glucocorticoids in water (ng/L) and sediments (ng/g dry weight) from Wuhan, China.
| Analyte | Water in summer (n = 19) | Water in autumn (n = 19) | Sediment in summer (n = 18) | Sediment in autumn (n = 19) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DF | Min | Max | Median | DF (%) | Min | Max | Median | DF (%) | Min | Max | Median | DF (%) | Min | Max | Median | ||
| Anti-virus drug | Ribavirin | 89.5 | 1.04 | 52.2 | 4.36 | 57.9 | 1.11 | 2.26 | 1.55 | 100 | 0.13 | 2.46 | 0.86 | 100 | 0.10 | 10.4 | 1.39 |
| Sulfonamides antibiotics | Sulfadimidine | 94.7 | 0.12 | 8.91 | 0.69 | 94.7 | 0.97 | 2.21 | 1.45 | 11.1 | 0.11 | 0.13 | 0.12 | 26.3 | 0.18 | 0.22 | 0.19 |
| Sulfamethoxazole | 84.2 | 1.12 | 16.6 | 8.48 | 94.7 | 1.42 | 11.7 | 2.63 | 11.1 | 0.18 | 0.19 | 0.18 | 10.5 | 0.11 | 0.11 | 0.11 | |
| Sulfadiazine | 63.2 | 0.10 | 2.56 | 0.49 | 57.9 | 0.84 | 9.14 | 1.48 | – | – | – | – | – | – | – | – | |
| Sulfamonomethoxine | 52.6 | 0.53 | 8.81 | 1.46 | 47.4 | 1.23 | 17.8 | 3.07 | 33.3 | 0.22 | 0.29 | 0.25 | 31.6 | 0.31 | 0.39 | 0.32 | |
| Sulfachloropyridazine | 42.1 | 0.59 | 8.15 | 1.42 | 42.1 | 0.90 | 6.00 | 3.50 | – | – | – | – | 26.3 | 0.09 | 0.10 | 0.09 | |
| Sulfaquinoxaline | 10.5 | 0.17 | 0.58 | 0.38 | 21.1 | 1.08 | 1.08 | 1.08 | – | – | – | – | 5.3 | 0.09 | 0.09 | 0.09 | |
| Sulfadimethoxine | 5.3 | 0.18 | 0.18 | 0.18 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Sulfamethizole | 5.3 | 1.36 | 1.36 | 1.36 | – | – | – | – | – | – | – | – | 10.5 | 0.01 | 0.13 | 0.07 | |
| Sulfamerazine | 5.3 | 0.11 | 0.11 | 0.11 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Sulfisoxazole | – | – | – | – | – | – | – | – | 33.3 | 0.28 | 0.35 | 0.31 | – | – | – | – | |
| ΣSulfonamides | – | 0.33 | 24.9 | 16.5 | – | 2.39 | 32.5 | 10.0 | – | 0.11 | 0.78 | 0.29 | – | 0.01 | 0.70 | 0.39 | |
| Fluoroquinolones antibiotics | Norfloxacin | 10.5 | 0.49 | 4.51 | 2.50 | 11.1 | 0.62 | 2.65 | 1.63 | 21.1 | 1.84 | 25.2 | 6.27 | ||||
| Ofloxacin | 5.3 | 21.0 | 21.0 | 21.0 | 10.5 | 39.0 | 172 | 106 | 50.0 | 0.15 | 17.0 | 0.37 | 89.5 | 0.04 | 125 | 0.73 | |
| Moxifloxacin hydrochloride | – | – | – | – | – | – | – | – | 33.3 | 0.87 | 2.80 | 1.49 | 31.6 | 0.53 | 2.26 | 0.76 | |
| Enoxacin | – | – | – | – | – | – | – | – | 27.8 | 0.11 | 8.48 | 0.54 | 10.5 | 2.62 | 3.47 | 3.04 | |
| Enrofloxacin | – | – | – | – | – | – | – | – | 22.2 | 0.10 | 5.45 | 1.10 | 31.6 | 0.02 | 7.70 | 0.06 | |
| Ciprofloxacin | – | – | – | – | – | – | – | – | 16.7 | 0.11 | 0.38 | 0.12 | 31.6 | 0.17 | 0.78 | 0.24 | |
| ΣFluoroquinolones | – | 0.49 | 21.0 | 4.51 | – | 39.0 | 172 | 106 | – | 0.11 | 19.2 | 1.64 | – | 0.08 | 152 | 1.40 | |
| Macrolides antibiotics | Erythromycin | 100 | 0.06 | 5.75 | 0.49 | 78.9 | 0.91 | 12.9 | 1.15 | 61.1 | 0.10 | 8.51 | 0.38 | 73.7 | 0.14 | 0.37 | 0.16 |
| Azithromycin | 94.7 | 3.14 | 935 | 43.9 | 84.2 | 1.98 | 920 | 17.4 | 83.3 | 2.70 | 41.1 | 12.6 | 52.6 | 0.43 | 39.2 | 4.87 | |
| Clarithromycin | 89.5 | 0.18 | 266 | 5.93 | 10.5 | 1.65 | 1.99 | 1.82 | 5.6 | 2.10 | 2.10 | 2.10 | – | – | – | – | |
| Tilmicosin | 42.1 | 1.26 | 7.30 | 2.60 | 10.5 | 4.80 | 11.3 | 8.03 | 66.7 | 0.12 | 14.5 | 2.88 | – | – | – | – | |
| Tylosin | 5.3 | 2.14 | 2.14 | 2.14 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Spiramycin | – | – | – | – | – | – | – | – | – | – | – | – | 42.1 | 0.95 | 1.05 | 0.97 | |
| ΣMacrolides | – | 0.06 | 1100 | 29.6 | – | 1.07 | 937 | 16.1 | – | 0.19 | 45.5 | 14.0 | – | 0.14 | 40.6 | 1.56 | |
| Glucocorticoids | Triamcinolone acetonide | 21.1 | 0.28 | 0.89 | 0.35 | 10.5 | 1.13 | 2.24 | 1.68 | – | – | – | – | – | – | – | – |
| Hydrocortisone | 10.5 | 0.64 | 2.03 | 1.34 | 10.5 | 0.90 | 2.18 | 1.54 | – | – | – | – | 10.5 | 0.01 | 0.02 | 0.01 | |
| Budesonide | 10.5 | 6.65 | 15.5 | 11.1 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Beclomethasone | 5.3 | 32.5 | 32.5 | 32.5 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Hydrocortisone 17-valerate | 5.3 | 1.17 | 1.17 | 1.17 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Prednicarbate | 5.3 | 0.27 | 0.27 | 0.27 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Mometasone furoate | 5.3 | 10.8 | 10.8 | 10.8 | – | – | – | – | – | – | – | – | – | – | – | – | |
| Cortisone | – | – | – | – | 26.3 | 0.47 | 3.69 | 0.91 | – | – | – | – | – | – | – | – | |
| Fludroxycortide | – | – | – | – | 10.5 | 2.86 | 5.36 | 4.11 | – | – | – | – | – | – | – | – | |
| Fluoromethalone | – | – | – | – | 10.5 | 0.66 | 0.67 | 0.67 | – | – | – | – | 10.5 | 0.10 | 0.11 | 0.10 | |
| Prednisone 21-acetate | – | – | – | – | – | – | – | – | 100 | 0.22 | 0.88 | 0.48 | 5.3 | 0.01 | 0.01 | 0.01 | |
| Hydrocortisone 21-acetate | – | – | – | – | – | – | – | – | – | – | – | – | 15.8 | 0.02 | 0.03 | 0.03 | |
| Prednisolone | – | – | – | – | – | – | – | – | – | – | – | – | 5.3 | 0.08 | 0.08 | 0.08 | |
| ΣGlucocorticoids | – | 0.28 | 32.5 | 2.03 | – | 0.47 | 5.72 | 2.99 | – | 0.22 | 0.88 | 0.48 | – | 0.01 | 0.12 | 0.03 | |
DF: detection frequency.
Fig. 2Occurrence of five categories of PPCPs in surface water from Wuhan City. (A) Spatial and seasonal distributions of PPCPs in three regions. (B) The composition of PPCPs in surface water in summer. (C) The composition of PPCPs in surface water in autumn. RBV: ribavirin; FQs: fuoroquinolones; SAs: sulfonamides; MLs: macrolides; GC: glucocorticoids.
Fig. 3Occurrence of five categories of PPCPs in sediments from Wuhan City.
(A) Spatial and seasonal distributions of PPCPs in three regions. (B) The composition of PPCPs in sediments in summer. (C) The composition of PPCPs in sediments in summer. RBV: ribavirin; FQs: fuoroquinolones; SAs: sulfonamides; MLs: macrolides; GC: glucocorticoids.
Estimated mass loading of determined drugs from three WWTPs in Wuhan post COVID-19 pandemic.
| Drugs | WWTP-J (kg) | WWTP-H (kg) | WWTP-L (kg) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| March–June | July–October | Total | March–June | July–October | Total | March–June | July–October | Total | |
| Antiviral drug | 0.34 | 0.04 | 0.38 | 0.04 | 0.01 | 0.05 | 0.01 | 0.00 | 0.01 |
| Sulfonamides | 0.68 | 0.54 | 1.22 | 0.08 | 0.18 | 0.26 | 0.17 | 0.04 | 0.21 |
| 0.20 | 6.36 | 6.56 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.06 | |
| Macrolides | 5.46 | 26.3 | 31.7 | 0.12 | 2.14 | 2.26 | 7.75 | 0.46 | 8.22 |
| Glucocorticoids | 0.01 | 0.08 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Total (kg) | 6.69 | 33.3 | 40.0 | 0.25 | 2.32 | 2.57 | 8.00 | 0.50 | 8.50 |
Fig. 4RQs of detected PPCPs to the most sensitive species across sampling sites.
The risk quotients (RQ) based on the measured concentration of PPCPs in surface water at an individual location of Wuhan City in summer (A) and autumn (B). SAs: sulfonamides; FQs: fuoroquinolones; MLs: macrolides; GCs: glucocorticoids; RBV: ribavirin; SMZ: sulfamerazine; SMIZ: sulfamethizole; SDM: sulfadimidine; SCP: sulfachloropyridazine; SDX: sulfadimethoxine; SQL: sulfaquinoxaline; SDZ: sulfadiazine; SMM: sulfamonomethoxine; SMO: sulfamethoxazole; NFX: norfloxacin; TMS: tilmicosin; OFX: ofloxacin; TYL: tylosin; EM: erythromycin; AZM: azithromycin; CLA: clarithromycin; HYD: hydrocortisone; BEC: beclomethasone; TAA: triamcinolone acetonide acetate; BUD: budesonide; MF: mometasone furoate; COR: cortisone; FM: fluoromethalone; FC: fludroxycortide.
Fig. 5The RQm (A), frequency of exceeded PNEC (B) and prioritization indexes (C) based on the median concentration of PPCPs in surface water of Wuhan City.